warnings
Warnings Use only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children.
G-18
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- G-18
- Generic name
- FRAXINUS EXCELSIOR LEAF
- Manufacturer
- DNA Labs, Inc.
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 8f21c2a7-825c-44de-9341-8a66b2c0e08a
- SPL ID
- 2b532077-bbdb-534d-e063-6394a90a4a26
- Version
- 3
- Effective date
- 2025-01-09
- Source export date
- 2026-10-27
- Source partition
- 2
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-27/29a1aba6a935d72bab5474118c2ccf25cb52dfe8488fe1593c734ea6c04e3722/drug-label-0002-of-0014.json.zip
- Source manifest SHA-256
- 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
- Import run
- 20261027T193451Z
- Imported at
- 2026-10-27 19:46:35
| Harmonized routes |
|---|
| SUBLINGUAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | G-18 | openfda.brand_name | |
| generic name | FRAXINUS EXCELSIOR LEAF | openfda.generic_name | |
| manufacturer name | DNA Labs, Inc. | openfda.manufacturer_name | |
| ndc | package | 58264-0381-2 | openfda.package_ndc |
| ndc | product | 58264-0381 | openfda.product_ndc |
| ndc11 | package | 58264038102 | derived:openfda.package_ndc |
| spl id | 2b532077-bbdb-534d-e063-6394a90a4a26 | id | |
| spl set id | 8f21c2a7-825c-44de-9341-8a66b2c0e08a | set_id | |
| unii | RC38362Q7M | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.